Volume | 30,895 |
|
|||||
News | - | ||||||
Day High | 13.00 | Low High |
|||||
Day Low | 11.99 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Greenwich LifeSciences Inc | GLSI | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
12.52 | 11.99 | 13.00 | 12.34 | 12.62 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
840 | 30,895 | $ 12.41 | $ 383,398 | - | 7.58 - 21.44 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
18:04:55 | 1 | $ 12.34 | USD |
Greenwich LifeSciences Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
157M | 12.85M | - | 0 | -7.83M | -0.61 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Greenwich LifeSciences News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GLSI Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 12.86 | 14.136 | 11.375 | 12.71 | 42,260 | -0.52 | -4.04% |
1 Month | 20.10 | 20.55 | 11.375 | 15.39 | 37,551 | -7.76 | -38.61% |
3 Months | 8.73 | 21.44 | 8.00 | 14.45 | 54,568 | 3.61 | 41.35% |
6 Months | 8.07 | 21.44 | 7.58 | 13.28 | 34,844 | 4.27 | 52.91% |
1 Year | 10.98 | 21.44 | 7.58 | 12.17 | 26,571 | 1.36 | 12.39% |
3 Years | 35.56 | 48.96 | 6.8241 | 18.39 | 70,514 | -23.22 | -65.30% |
5 Years | 5.00 | 158.07 | 3.262 | 36.97 | 163,083 | 7.34 | 146.80% |
Greenwich LifeSciences Description
Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in most breast cancers at low, intermediate, and high or overexpressor levels. |